Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-escalation Tolerability Study of Levodopa/Carbidopa in Angelman Syndrome

NCT00829439 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.

NCT NCT00829439
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00829439 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-escalation Tolerability Study of Levodopa/Carbidopa in Angelman Syndrome
Lead sponsor
Boston Children's Hospital
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2009
Completion date
June 30, 2010
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angelman syndrome